COMPANIES›GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP
✓ Verified H1B Sponsor

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP

Cambridge, MAEIN 010852078
TRUST SCORE
84.8
High Trust
7
FY2024 H1B Approvals
8
All-time Approvals
84.8
Trust Score / 100

TOP SPONSORED JOB CATEGORIES

BiostatisticiansOperations Research AnalystsSupply Chain Managers

RECENT H1B FILINGS

JOB TITLELOCATIONWAGEDATE
Biochemists and BiophysicistsCambridge, MA$105,851Nov 2025
Industrial EngineersCambridge, MA$157,000Oct 2025
Industrial Production ManagersCambridge, MA$113,870Jul 2025
Manufacturing EngineersCambridge, MA$130,582Jun 2025
Validation EngineersCambridge, MA$121,170Jun 2025
Supply Chain ManagersCambridge, MA$151,882Feb 2025
BiostatisticiansCambridge, MA$88,899Jan 2025
BiostatisticiansCambridge, MA$88,899Jan 2025
Operations Research AnalystsCambridge, MA$105,750Aug 2024

SHOWING 50 MOST RECENT · SOURCE: DOL LCA PUBLIC DATA FY2024 · EIN 010852078

FREQUENTLY ASKED QUESTIONS

Does GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP sponsor H1B visas?

Yes. GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP has an active H1B sponsorship history with 8 total approved LCA filings on record, including 7 approvals in FY2024. Data sourced from US Department of Labor public disclosure files.

How many H1B visas has GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP sponsored?

According to DOL LCA data, GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP has 8 all-time H1B approvals and 7 approvals in fiscal year 2024.

What types of roles does GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP sponsor H1B for?

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP most commonly sponsors H1B visas for: Biostatisticians, Operations Research Analysts, Supply Chain Managers. This is based on their DOL Labor Condition Application filing history.

Is GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP a reliable H1B sponsor?

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP has a Trust Score of 84.8/100 on KEEL, calculated from total approval volume, recency of filings, and approval consistency based on DOL LCA data.

DATA SOURCE: US DEPT. OF LABOR · LCA PUBLIC DISCLOSURE FY2023–FY2024